The Devi Shetty-run hospital company has allotted 73.57 lakh equity shares at Rs 250 per share aggregating to Rs 183.93 crore to anchors investors like Morgan Stanley, Mirae Asset Management, Nomura, Government of Singapore, Reliance AMC, Birla Sun Life, DSP Blackrock, UTI, ICICI Prudential, SBI MF among others.
The IPO opens on December 17 and closes on December 21 and the company has set price band of Rs 245-250 for the sale.
The IPO includes an offer of sale of up to 2.45 crore equity shares representing 14.04 per cent stake in the company by the promoters and other existing shareholders.
While the government of Singapore picked up 3.95 per cent, Monetary Authority of Singapore picked up 2.72 per cent in the issue, according to a statement from the company.
More From This Section
FIL Investments, Mauritius picked up 6.67 per cent, Mirae Asset Asia picked up 6.67 per cent, and Reliance Capital Trustee Co got 5.04 per cent while another Reliance Capital Trustee Co arm picked up 1.63 per cent.
The book running lead managers to the offer are Axis Capital, IDFC Securities and Jefferies India.
Shetty set up the hospital in 2000 and operates a chain of 23 multispecialty, tertiary and primary healthcare facilities and eight heart centres, and 24 primary care facilities across 31 cities, with 5,442 operational beds and the potential to reach a capacity of up to 6,602 beds.
As per Shetty, the company plans to set up four new hospitals at an estimated cost of around Rs 100 crore. The 241 bedded hospital at Vaishnodevi will be set up in public-private partnership (PPP) model and it will be ready in 12 months period.
"We are also setting up new hospital in Mumbai and 226 bedded facility in Lucknow. The company's new facility at Bhubaneshwar is still under discussion stage," he had said recently, adding that the company will also pursue inorganic growth for future expansion.
Narayana Hrudayalaya is the third company from healthcare sector to launch IPO this month after diagnostic chain Dr Lal PathLabs and pharmaceutical firm Alkem Laboratories.